Serum Institute to supply 10 crore doses of Covishield in June : Bulletin: Business Today
Business Today
Loading...
 

Serum Institute to supply 10 crore doses of Covishield in June

Loading the player...

Rashi Bisaria | May 31, 2021

COVID-19: Serum Institute to supply 10 crore doses of Covishield in June

Serum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to 10 crore doses of Covishield in June, official sources said on Sunday amid complaint by states about the shortage of anti-coronavirus vaccine jabs. In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandemic.

COVID-19 impact: Govt widens scope of Emergency Credit Scheme to help small businesses

The Centre has taken the decision to fine-tune its emergency credit guarantee scheme to give long-term relief to a broader section of small business borrowers. It widened the net of the Rs 3 lakh crore Emergency Credit Line Guarantee Scheme (ECLGS), which will now provide concessional loans to hospitals for establishing on-site oxygen generation plants.

Paytm board gives in-principle approval for Rs 22,000 crore IPO

Digital payments and financial services firm Paytm has been making headlines for its intended initial public offering (IPO), touted to be one of India's biggest, surpassing Coal India's IPO. The board of the company was scheduled to meet on Friday to deliberate on the Vijay Shekhar Sharma-helmed company's IPO plans. Latest developments suggest that the board has given its in-principle approval for the Rs 22,000 crore IPO.

COVID-19: Zydus Cadila plans trials for its vaccine in 5-12 years age group

Zydus Cadila is planning to start the trials of its COVID-19 vaccine, ZyCoV-D, in children of 5-12 years age group after covering adults and 12-18 years children under its ongoing clinical trials. The Ahmedabad-based company has covered over 800 children in 12-18 years age group under its trials. ZyCoV-D is a DNA plasmid vaccine, which uses a portion of the genetic code -- DNA or RNA -- in the virus to stimulate an immune response. Cadila is aiming to submit the emergency use application for the vaccine by June.

Google, Facebook begin updating websites to reflect appointment of grievance officers under IT rules

Large digital companies like Google and Facebook have begun updating their websites to reflect the appointment of the grievance officers under the new social media rules that came into effect recently. They have shared details with the IT Ministry as per the requirement of the new digital rules, but Twitter is still not following the norms. As per the rules, all intermediaries have to prominently publish on their website, app or both, the name of the grievance officer and his/her contact details as well as the mechanism by which a user or a victim may make a complaint.

More from this section